HMG-CoA reductase inhibitors improve acute ischemic stroke outcome

Statins reduce the risk of stroke recurrence, but the benefits of statins in improving outcome of acute stroke patients have not been well explored. We assessed potential effects of statins initiated before or within 4 weeks of stroke on 90-day outcome. Favorable outcomes were National Institutes of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Stroke (1970) 2005-06, Vol.36 (6), p.1298-1300
Hauptverfasser:	MOONIS, Majaz, KANE, Kevin, SCHWIDERSKI, Ute, SANDAGE, Bobby W, FISHER, Marc
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Brain Ischemia - drug therapy Cerebral Hemorrhage - drug therapy Cerebrovascular Disorders - drug therapy Female Follow-Up Studies Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology Male Medical sciences Middle Aged Multivariate Analysis Nervous system (semeiology, syndromes) Neurology Odds Ratio Pharmacology. Drug treatments Recurrence Regression Analysis Risk Severity of Illness Index Stroke - drug therapy Treatment Outcome Vascular diseases and vascular malformations of the nervous system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!